The follow-up of treatment for lupus determines the evolution of the disease
A recent study, led by the University of Granada, shows that the follow-up of treatment of patients with systemic lupus erythematosus (SLE) varies widely...
More news
IDIBAPS researchers unveil the keys to the genetic predisposition to leukemia
Researchers at IDIBAPS have published a study in Nature Communications in which they have deciphered the molecular basis of the genetic predisposition...
Home treatment improves the quality of life in myeloma patients
Patients with multiple myeloma and mobility problems who receive treatment at home improve their quality of life by avoiding repeated visits to the hospital.
Stem cells treatment for fistulas in Crohn's disease is about to be approved in Catalonia
Treatment with mesenchymal stem cells (MSCs), extracted from fat tissue, is a powerful tool for the cure of autoimmune diseases such as Crohn's disease.
Late motherhood, a new social and health phenomenon
The desire of women to be pregnant after 35 and even 40 years of age has become an important social phenomenon. Increasingly, women are delaying the moment...
Evolution of cancer immunotherapy: from bone marrow transplant to CAR
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining the...
The eyes: excellent candidates for stem cell therapies
Replacing the cells of a damaged tissue with healthy ones using stem cells is now a reality. In the case of the eyes, the use of these new therapies has...
The Telemedicine Platform Trip Doctor is Awarded the 2019 GEBTA Prize
The Barcelona Institute for Global Health (ISGlobal) and the Hospital Clinic of Barcelona received the 2019 GEBTA Initiative Award for Trip Doctor, the...
Correcting overweight during childhood reduces the risk of developing type 2 diabetes
Children with childhood obesity have a higher risk of developing type 2 diabetes mellitus (DM2) as adults. However, a study published in 2018 shows that...
A new molecular mechanism could explain the origins of the depressive symptoms in Huntington’s disease
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before the...